Bod Australia Limited (ASX:BDA, Bod) is a developer and distributor of natural, evidence-based health products with a focus on plant-based extracts and medicinal CBD. Bod is actively commercialising a range of over-the-counter and prescription products based on its unique, standardised, pharmaceutical-grade extracts.
The company has an extensive distribution footprint in Australia, selling a variety of prescription and OTC products to over 1,000 retail outlets, including pharmacies, retail stores and healthcare chains. Bod has also partnered with the innovation arm of the multi-billion-dollar Hong Kong listed H&H group, NewH2, to commercialise a range of OTC products using Bod's extracts. NewH2 is a recent strategic investor in Bod after investing $5.5m for a 17.64% stake in the company.